指南与共识妇科产科

为携带BRCA突变的跨性别患者制定乳腺癌和妇科癌症指南

Creating Breast and Gynecologic Cancer Guidelines for Transgender Patients With BRCA Mutations.
指南 / 共识 · Obstet Gynecol · 2021-01-01

本文总结针对顺性别患者的筛查、管理和监测策略,为携带BRCA突变的跨性别者提供相应建议,并指出未解问题。

要点

  • 跨性别者就医率低于顺性别者,受医疗歧视率更高。
  • 激素治疗对癌症风险因素的长期影响缺乏数据。
  • 需制定针对跨性别BRCA突变携带者的筛查和管理建议。

核心结论

  • 本文为携带BRCA突变的跨性别者提供基于顺性别患者策略的筛查、管理和监测建议,并强调需优先关注该人群并采用更包容的医学与研究框架。

研究设计与样本

  • 本文为评论文章,总结针对顺性别患者的筛查、管理和监测策略,为跨性别BRCA突变携带者提供相应建议。

主要发现

  • 跨性别者就医率低于顺性别患者,且受医疗歧视率高于顺性别患者。
  • 缺乏长期数据限制了对激素治疗影响该人群癌症风险因素的理解。
  • 针对该人群的癌症筛查和管理指南目前很少。

临床怎么用

  • 作者认为,由性别认同和性别肯定照护的细微差别指导的具体实践对于改善临床管理至关重要。
  • 作者认为,必须优先关注该人群并在医学和研究中采用更包容的框架。

局限性

  • 缺乏长期数据限制了对激素治疗影响该人群癌症风险因素的理解。
  • 针对该人群的癌症筛查和管理指南目前很少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

More than 1.5 million individuals in the United States identify as transgender. Transgender individuals have lower rates of health care utilization and higher rates of health care discrimination than cisgender patients. With a growing interest in providing comprehensive and compassionate care to the transgender community, there has been a concurrent increase in research on transgender health. However, lack of long-term data limits understanding the effects of hormone therapy on cancer risk factors in this population. This is particularly relevant for patients with hormonally mediated cancers and those at elevated risk from hereditary breast and ovarian cancer syndromes. Few cancer-screening and management guidelines currently exist for this population. Specific practices guided by the nuances of gender identity and gender-affirming care are essential to improve clinical management and to avoid further alienating a population that is already marginalized from the health care system. This commentary summarizes screening, management, and surveillance strategies devised for cisgender patients to offer corresponding recommendations tailored for transgender BRCA mutation carriers. In doing so, it highlights critical unanswered questions pertaining to the care of these patients. To address these questions, we must prioritize this population and adopt more inclusive frameworks in medicine and research.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bedrick BS, Fruhauf TF, Martin SJ, et al. Creating Breast and Gynecologic Cancer Guidelines for Transgender Patients With BRCA Mutations. Obstet Gynecol. 2021. PMID: 34735408. doi:10.1097/AOG.0000000000004597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。